MedPath
Found 1 clinical trials|View Analysis
Sort by:

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

Not Applicable
Completed
Conditions
Insulin Sensitivity
Multiple Mitochondrial Dysfunctions Syndrome
Interventions
Drug: Placebo
Drug: Dapagliflozin
First Posted Date
2011-09-23
Last Posted Date
2019-10-29
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
18
Registration Number
NCT01439854
Locations
🇺🇸

Diabetes Division, UTHSCSA, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath